Real-world use of inhaled nitric oxide therapy in patients with COVID-19 and mild-to-moderate acute respiratory distress syndrome

BACKGROUND: Inhaled nitric oxide (iNO) has been studied in patients with severe acute respiratory distress syndrome (ARDS) due to COVID-19 when it may be too late to impact disease course. This article aims to describe real-world iNO use and outcomes in patients with COVID-19 with mild-to-moderate A...

Descripción completa

Detalles Bibliográficos
Autores principales: Abman, Steven H, Fox, Nicholas R, Malik, M Ibrahim, Kelkar, Sneha S, Corman, Shelby L, Rege, Sanika, Bhaloo, Jenna, Shah, Rachel, Shei, Ren-Jay, Saporito, Dana, Shamseddine, Nisreen, DeBoer, Erik, Wan, George J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioExcel Publishing Ltd 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9007062/
https://www.ncbi.nlm.nih.gov/pubmed/35462641
http://dx.doi.org/10.7573/dic.2022-1-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9007062/
https://www.ncbi.nlm.nih.gov/pubmed/35462641
http://dx.doi.org/10.7573/dic.2022-1-4

Ejemplares similares